Electromagnetic Field Therapy to Improve Healing of Chronically Venous Ulcer
- Conditions
- Venous Ulcer PainChronic Venous Hypertension With Ulcer and Inflammation
- Interventions
- Device: Active Pulsed Electro-Magnetic Field (PEMF)Device: Placebo Pulsed Electro-Magnetic Field (PEMF)
- Registration Number
- NCT01561170
- Lead Sponsor
- Northern Orthopaedic Division, Denmark
- Brief Summary
Chronically venous ulcer in lower extremities is a permanent and disabling disease. Venous insufficience is the main cause of chronic ulcer. There is a high prevalence and frequency of the disease, primarily among elderly people. Recently, electromagnetic field therapy has been tested on various diseases in musculoskeletal system with a beneficial effect. In recent years, there has been an increasing interest in using electromagnetic field therapy to treat chronically venous ulcer.
The hypothesis of the investigators is that the electronic magnetic field therapy improves the healing process and reduces pain for patients suffering from chronically venous ulcer. The investigators assume that the bioactivity is affected by a cellular response which affects the DNA synthesis, transcription og protein synthesis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 36
- Patients who suffer from ulcer in lower extremities
- Patients who suffer from venous insufficience detected by duplex scanning or by a pressure on digits > 40 mmHg
- Patients with a regular need of compression stockings
- Age > 18 years
- Age < 18 years
- Unability to read or understand Danish
- Patients who suffer from manifest neoplastic disorder
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Chronically venous ulcer Active Pulsed Electro-Magnetic Field (PEMF) A group of 36 patients Chronically venous ulcer Placebo Pulsed Electro-Magnetic Field (PEMF) A group of 36 patients
- Primary Outcome Measures
Name Time Method Reduction of ulcerous area. 3 months Measurement of ulcerous area in order to assessing the effect of the healing process.
- Secondary Outcome Measures
Name Time Method Pain reduction in proportion to Visual Analogue Scale (VAS). 3 months The pain reduction will be measured by VAS and an analysis of the medication between the two group of patients will be carried out in order to measure quality of life, adverse effects, ulceration, granulation tissue etc.
Trial Locations
- Locations (1)
Northern Orthopaedic Division, Aalborg University Hospital,
🇩🇰Aalborg, Denmark